NCCIH Workshop 2020: Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes, 66344 [2020-22990]

Download as PDF 66344 Federal Register / Vol. 85, No. 202 / Monday, October 19, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting NCCIH Workshop 2020: Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIDCD. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual grant applications conducted by the National Institute On Deafness And Other Communication Disorders, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. jbell on DSKJLSW7X2PROD with NOTICES Name of Committee: Board of Scientific Counselors, NIDCD. Date: November 2, 2020. Time: 4:00 p.m. to 4:45 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: Porter Neuroscience Research Center, Building 35A, 35 Convent Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Thomas Baer Friedman, Ph.D., Chief, Laboratory of Molecular Medicine, National Institute on Deafness & Comm Disorders, National Institute of Health, 35 Convent Drive, Bethesda, MD 20892, (301) 496–7882, friedman@ nidcd.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// www.nidcd.nih.gov/about/advisorycommittees, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS). Dated: October 14, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–23076 Filed 10–16–20; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:05 Oct 16, 2020 Jkt 253001 AGENCY: National Institutes of Health, HHS. ACTION: Dated: October 13, 2020. Helene Langevin, Director, National Center for Complementary and Integrative Health, National Institutes of Health. [FR Doc. 2020–22990 Filed 10–16–20; 8:45 am] BILLING CODE 4140–01–P Notice. The National Center for Complementary and Integrative Health (NCCIH) will hold a workshop on October 23, 2020. The topic of this workshop will be ‘‘Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes’’. The overall goals of this workshop are to convene principal investigators funded by NCCIH on the topic of the analgesic properties of minor cannabinoids and terpenes from natural products and the underlying mechanisms as well as to discuss current research barriers and opportunities on this topic. DATES: The Meeting will be held on October 23, 2020, from 9:45 a.m. to 3:00 p.m. (ET). ADDRESSES: This workshop will be livestreamed via videocast. Registration is requested via https://nccih_cbd_ workshop.eventbrite.com. SUMMARY: For information concerning this meeting, contact Dr. Inna Belfer, Program Director, Basic and Mechanistic Research, Division of Extramural Research, National Center for Complementary and Integrative Health, Telephone: 301–435–1573; Email: inna.belfer@nih.gov. SUPPLEMENTARY INFORMATION: In accordance with 42 U.S.C. 287c–21, of the Public Health Service Act, as amended and in keeping with the mission of the National Center for Complementary and Integrative Health (NCCIH) is to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative interventions and their roles in improving health and health care. This workshop is aligned with NCCIH’s mission to support research on the fundamental science, safety, and usefulness of complementary and integrative health approaches. Specifically, minor cannabinoids and terpenes from natural products are part of complementary interventions supported by NCCIH. The workshop is also aligned with NCCIH’s strategic goals of advancing understanding of FOR FURTHER INFORMATION CONTACT: PO 00000 basic biological mechanisms of action of natural products and improving care for hard-to-manage symptoms, such as pain. Frm 00045 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 04, 2020, 09:00 a.m. to November 05, 2020, 02:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on October 06, 2020, 85 FR Page 63123. The meeting is scheduled for 11/04/ 2020 starting at 9:00 a.m. and ending on 11/05/2020 at 2:00 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: October 13, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–23044 Filed 10–16–20; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\19OCN1.SGM 19OCN1

Agencies

[Federal Register Volume 85, Number 202 (Monday, October 19, 2020)]
[Notices]
[Page 66344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22990]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


NCCIH Workshop 2020: Exploring the Mechanisms Underlying 
Analgesic Properties of Minor Cannabinoids and Terpenes

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Center for Complementary and Integrative Health 
(NCCIH) will hold a workshop on October 23, 2020. The topic of this 
workshop will be ``Exploring the Mechanisms Underlying Analgesic 
Properties of Minor Cannabinoids and Terpenes''. The overall goals of 
this workshop are to convene principal investigators funded by NCCIH on 
the topic of the analgesic properties of minor cannabinoids and 
terpenes from natural products and the underlying mechanisms as well as 
to discuss current research barriers and opportunities on this topic.

DATES: The Meeting will be held on October 23, 2020, from 9:45 a.m. to 
3:00 p.m. (ET).

ADDRESSES: This workshop will be livestreamed via videocast. 
Registration is requested via https://nccih_cbd_workshop.eventbrite.com.

FOR FURTHER INFORMATION CONTACT: For information concerning this 
meeting, contact Dr. Inna Belfer, Program Director, Basic and 
Mechanistic Research, Division of Extramural Research, National Center 
for Complementary and Integrative Health, Telephone: 301-435-1573; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: In accordance with 42 U.S.C. 287c-21, of the 
Public Health Service Act, as amended and in keeping with the mission 
of the National Center for Complementary and Integrative Health (NCCIH) 
is to define, through rigorous scientific investigation, the usefulness 
and safety of complementary and integrative interventions and their 
roles in improving health and health care. This workshop is aligned 
with NCCIH's mission to support research on the fundamental science, 
safety, and usefulness of complementary and integrative health 
approaches. Specifically, minor cannabinoids and terpenes from natural 
products are part of complementary interventions supported by NCCIH. 
The workshop is also aligned with NCCIH's strategic goals of advancing 
understanding of basic biological mechanisms of action of natural 
products and improving care for hard-to-manage symptoms, such as pain.

    Dated: October 13, 2020.
Helene Langevin,
Director, National Center for Complementary and Integrative Health, 
National Institutes of Health.
[FR Doc. 2020-22990 Filed 10-16-20; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.